Mon, Jul 14, 2014, 8:05 AM EDT - U.S. Markets open in 1 hr 25 mins

Recent

% | $
Quotes you view appear here for quick access.

Muscle Pharm Corp. Message Board

acpinvestor 9 posts  |  Last Activity: Mar 28, 2014 11:39 AM Member since: Apr 12, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    I'm holding on for dear life!

    by cohencorp Mar 7, 2014 7:03 PM
    acpinvestor acpinvestor Mar 28, 2014 11:39 AM Flag

    Looks like there is some progress on the uplisting front: "On March 21, 2014, the Company created a Financial Disclosure Committee (the "Committee"), which shall be comprised of certain officers and directors of the Company, as appointed by the Company's Chief Executive Officer for the general purpose of assuring the Company's disclosures to its security holders or the investment community will be accurate and complete and will be made on a timely basis as required by applicable laws and stock exchange requirements.

    http://biz.yahoo.com/e/140326/mslp8-k.html

    Sentiment: Buy

  • Reply to

    update to shareholders

    by mtc44380 Jan 29, 2014 9:41 AM
    acpinvestor acpinvestor Jan 31, 2014 12:41 PM Flag

    EPS guidance is on GAAP basis meaning after non-cash charges. 2012 EPS of $ -13.0 in the table confirms that.

    Sentiment: Buy

  • Reply to

    Jonathan Lebed Shorting MSLP

    by slapthatpig Nov 13, 2013 1:17 PM
    acpinvestor acpinvestor Nov 13, 2013 2:52 PM Flag

    This was in the planning since the September investment into BZNE. They are acquiring manufacturing capabilities. At current share price levels the downside is quite limited compared with the potential upside from all the various strategic deals that have been announced over the last 6 months. You might want to find a better way to channel your anger then posting these nonsensical rants.

    Sentiment: Buy

  • acpinvestor by acpinvestor Oct 28, 2013 12:20 PM Flag

    Anyone know when they will announce Q3 earnings?

    Sentiment: Buy

  • Reply to

    Back Up The Truck

    by coachk77772000 Oct 15, 2013 8:43 AM
    acpinvestor acpinvestor Oct 17, 2013 4:25 PM Flag

    $20 is a conservative estimate. This is still a growth story. Profitability on the EBIT level will be sufficient at this stage. I expect an upward revision on the FY2013 revenue guidance when Q3 numbers come out which should drive the share price. Any update on the uplisting and nature of the SEC investigation will further drive upside

    Sentiment: Strong Buy

  • Reply to

    Arnold #18 today

    by gjcarlson Oct 8, 2013 8:26 AM
    acpinvestor acpinvestor Oct 8, 2013 9:50 AM Flag

    Iron Mass already sold out and on backorder. Same for the UK site. Think it is a bit early to draw conclusions here

  • Reply to

    SEC Investigation

    by chicharonegood Oct 1, 2013 8:50 AM
    acpinvestor acpinvestor Oct 1, 2013 10:06 AM Flag

    Something like this was expected given the delay on the uplisting but will not be detrimental to the company's future.

    Sentiment: Strong Buy

  • Reply to

    If we can make it to the end of next week...

    by fkk_kass Sep 19, 2013 10:16 AM
    acpinvestor acpinvestor Sep 23, 2013 6:28 PM Flag

    I presume you meant Series D? From the recently filed S-1 "As of August 19, 2013, 1,355,000 Series D shares have been converted into 2,710,000 shares of the Company’s common stock and 145,000 shares of Series D preferred stock remain outstanding."

    There is a bit of restricted stock vesting overhang. Keep in mind Arnold received 780k shares so really need the fundamental financials to be solid and profitable. No more one off adjustments and add backs...

    Sentiment: Strong Buy

  • Reply to

    NASDAQ LISTING

    by mtc44380 Aug 10, 2013 8:53 AM
    acpinvestor acpinvestor Aug 13, 2013 1:40 PM Flag

    The Nasdaq listing is not necessarily going to lead to increased analyst coverage as the market cap is still fairly low for any big brokerage to get excited. On the upside, a NASDAQ listing will bring increased liquidity and the involvement of market makers which will put the company on the radar screen for institutional investors who so far were no able to hold the shares given the low trading volumes. Meeting or exceeding revenue and EPS guidance going forward will be the key driver of the share price. Recent developments seem supportive of further revenue growth. Wednesday will key for setting growth expectations.

    Sentiment: Buy

MSLP
11.98-0.07(-0.58%)Jul 11 3:54 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.